MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma

Clinical trial NCT00543582 · TERMINATED

Trial details

NCT number: NCT00543582
Sponsor: Mirati Therapeutics Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)

Start date: 2007-10-01
Primary completion: 2009-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.